Join

Compare · AKYA vs TXG

AKYA vs TXG

Side-by-side comparison of Akoya BioSciences Inc. (AKYA) and 10x Genomics Inc. (TXG): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AKYA and TXG operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • TXG is the larger of the two at $9.43B, about 24.3x AKYA ($388.8M).
  • TXG has hit the wire 6 times in the past 4 weeks while AKYA has been quiet.
  • TXG has more recent analyst coverage (25 ratings vs 13 for AKYA).
MetricAKYATXG
Company
Akoya BioSciences Inc.
10x Genomics Inc.
Price
$1.30-5.80%
$69.87-3.47%
Market cap
$388.8M
$9.43B
1M return
-
-9.24%
1Y return
-
+431.53%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NASDAQ
IPO
2021
2019
News (4w)
0
6
Recent ratings
13
25
AKYA

Akoya BioSciences Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

TXG

10x Genomics Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Latest AKYA

Latest TXG